Primate models of schizophrenia: Future possibilities

Progress in Brain Research

Volumn 179, Issue C, 2009, Pages 117-125

  Simen, Arthur A ^a   DiLeone, Ralph ^a   Arnsten, Amy F T ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

DISC1; Evolution; Prefrontal cortex; Primate; Working memory

Indexed keywords

ANIMAL; CYTOLOGY; DISEASE MODEL; GENE VECTOR; GENETICS; GROWTH, DEVELOPMENT AND AGING; HISTOLOGY; HUMAN; METHODOLOGY; MOLECULAR BIOLOGY; NERVE CELL; NERVE CELL NETWORK; PATHOPHYSIOLOGY; PHYSIOLOGY; PREFRONTAL CORTEX; PRIMATE; REVIEW; SCHIZOPHRENIA;

ANIMALS; DISEASE MODELS, ANIMAL; GENETIC VECTORS; HUMANS; MOLECULAR BIOLOGY; NERVE NET; NEURONS; PREFRONTAL CORTEX; PRIMATES; SCHIZOPHRENIA;

EID: 77953374515     PISSN: 00796123     EISSN: 18757855     Source Type: Book Series    
DOI: 10.1016/S0079-6123(09)17913-X     Document Type: Article

References (59)

1. Arango, C., Mareno, C., Martinez, S., Parellada, M., Desco, M., Moreno, D., et al. (2008). Longitudinal brain changes in earlyonset psychosis. Schizophr Bull, 34, 341-353.
2. Aucoin, M. G., Perrier, M., & Kamen, A. A. (2008). Critical assessment of current adeno-associated viral vector production and quantification methods. Biotechnology Advances, 26, 73-88.
3. Barch, D. M. (2005). The cognitive neuroscience of schizophrenia. Annual Review of Clinical Psychology, 1, 321-353.
4. Bord, L., et al. (2006). Primate disrupted-in-schizophrenia-1 (DISC1): High divergence of a gene for major mental illnesses in recent evolutionary history. Neuroscience Research, 56, 286-293.
5. Brandon, N. J. (2007). Dissecting DISC1 function through protein-protein interactions. Biochemical Society Transactions, 35, 1283-1286.
6. Broekman, M. L., et al. (2006). Adeno-associated virus vectors serotyped with AAV8 capsid are more efficient than AAV-1 or -2 serotypes for widespread gene delivery to the neonatal mouse brain. Neuroscience, 138, 501-510.
7. Buning, H., et al. (2008). Recent developments in adenoassociated virus vector technology. Journal of Gene Medicine, 10, 717-733.
8. Corlett, P. R., et al. (2007). Disrupted prediction-error signal in psychosis: Evidence for an associative account of delusions. Brain, 130(Pt 9), 2387-2400.
9. Coyle, J. T., et al. (2003). Converging evidence of NMDA receptor hypofunction in the pathophysiology of schizophrenia. Annals of the New York Academy of Sciences, 1003, 318-327.
10. Davis, R. H. (2004). The age of model organisms. Nature Reviews Genetics, 5, 69-76.
11. Duffy, A. M., et al. (2009). Spatial and intracellular relationships between the alpha7 nicotinic acetylcholine receptor and the vesicular acetylcholine transporter in the prefrontal cortex of rat and mouse. Neuroscience, 161, 1091-1103.
12. Elston, G. N., et al. (2006). Specializations of the granular prefrontal cortex of primates: Implications for cognitive processing. The Anatomical Record. Part A, Discoveries in Molecular, Cellular, and Evolutionary Biology, 288, 26-35.
13. Feng, X., et al. (2004). Adeno-associated viral vector-mediated ApoE expression in Alzheimer's disease mice: Low CNS immune response, long-term expression, and astrocyte specificity. Frontiers in Bioscience, 9, 1540-1546.
14. Ford, J. M., et al. (2002). Reduced communication between frontal and temporal lobes during talking in schizophrenia. Biological Psychiatry, 51, 485-492.
15. Girod, A., et al. (1999). Genetic capsid modifications allow efficient re-targeting of adeno-associated virus type 2. Nature Medicine, 5, 1052-1056.
16. Glantz, L. A., & Lewis, D. A. (2000). Decreased dendritic spine density on prefrontal cortical pyramidal neurons in schizophrenia. Archivesof General Psychiatry, 57, 65-73.
17. Goldman-Rakic, P. S. (1995). Cellular basis of working memory. Neuron, 14, 477-485.
18. Grimm, D., & Kay, M. A. (2003). From virus evolution to vector revolution: use of naturally occurring serotypes of adeno-associated virus (AAV) as novel vectors for human gene therapy. Curr Gene Ther, 3, 281-304.
19. Hao, J., et al. (2007). Interactive effects of age and estrogen on cognition and pyramidal neurons in monkey prefrontal cortex. Proceedings of the National Academy of Sciences of the United States of America, 104, 11465-11470.
20. Hoffman, R. E., et al. (2005). Temporoparietal transcranial magnetic stimulation for auditory hallucinations: Safety, efficacy and moderators in a fifty patient sample. Biological Psychiatry, 58, 97-104.
21. Hommel, J. D., et al. (2003). Local gene knockdown in the brain using viral-mediated RNA interference. Nature Medicine, 9, 1539-1544.
22. Howard, D. B., et al. (2008). Tropism and toxicity of adenoassociated viral vector serotypes 1, (2, (5, (6, (7, (8, and 9 in rat neurons and glia in vitro. Virology, 372, 24-34.
23. Jacobs, B., et al. (2001). Regional dendritic and spine variation in human cerebral cortex: A quantitative golgi study. Cerebral Cortex, 11, 558-571.
24. Johnson, M. B., et al. (2009). Functional and evolutionary insights into human brain development through global transcriptome analysis. Neuron, 62, 494-509.
25. Kaplitt, M. G., et al. (1994). Long-term gene expression and phenotypic correction using adeno-associated virus vectors in the mammalian brain. Nature Genetics, 8, 148-154.
26. Kirkpatrick, B., et al. (2006). DISC1 immunoreactivity at the light and ultrastructural level in the human neocortex. The Journal of Comparative Neurology, 497, 436-450.
27. Klein, R. L., et al. (2006). Efficient neuronal gene transfer with AAV8 leads to neurotoxic levels of tau or green fluorescent proteins. Molecular Therapy, 13, 518-527.
28. Koerber, J. T., et al. (2007). Engineering adeno-associated virus for one-step purification via immobilized metal affinity chromatography. Human Gene Therapy, 18, 367-378.
29. Lewis, D. A., & Gonzalez-Burgos, G. (2006). Pathophysiologically based treatment interventions in schizophrenia. Nature Medicine, 12, 1016-1022.
30. Lewis, D. A., & Levitt, P. (2002). Schizophrenia as a disorder of neurodevelopment. Annual Review of Neuroscience, 25, 409-432.
31. Lewis, D. A., & Sweet, R. A. (2009). Schizophrenia from a neural circuitry perspective: Advancing toward rational pharmacological therapies. The Journal of Clinical Investigation, 119, 706-716.
32. Lo, W. D., et al. (1999). Adeno-associated virus-mediated gene transfer to the brain: Duration and modulation of expression. Human Gene Therapy, 10, 201-213.
33. Ma, L., et al. (2002). Cloning and characterization of DISC1, the mouse ortholog of DISC1 (Disrupted-in-Schizophrenia 1). Genomics, 80, 662-672.
34. Maheshri, N., et al. (2006). Directed evolution of adenoassociated virus yields enhanced gene delivery vectors. Nature Biotechnology, 24, 198-204.
35. Mello, C. C., & Conte, D. J. (2004). Revealing the world of RNA interference. Nature, 431, 338-342.
36. Millar, J. K., Christie, S., Anderson, S., Lawson, D., Hsiao Wei Loh, D., Devon, R. S., et al. (2001). Genomic structure and localisation within a linkage hotspot of Disrupted In Schizophrenia 1, a gene disrupted by a translocation segregating with schizophrenia. Mol Psychiatry, 6, 173-178.
37. Millar, J. K., et al. (2007). Disrupted in schizophrenia 1 and phosphodiesterase 4B: Towards an understanding of psychiatric illness. Journal of Physiology, 584, 401-405.
38. Mingozzi, F., & High, K. A. (2007). Immune responses to AAV in clinical trials. Current Gene Therapy, 7, 316-324.
39. Nugent, T. F., 3rd, Herman, D. H., Ordonez, A., Greenstein, D., Hayashi, K. M., Lenane, M., et al. (2007). Dynamic mapping of hippocampal development in childhood onset schizophrenia. Schizophr Res, 90, 62-70.
40. Perlstein, W. M., et al. (2001). Relation of prefrontal cortex dysfunction to working memory and symptoms in schizophrenia. American Journal of Psychiatry, 158, 1105-1113.
41. Porteous, D. J., & Millar, J. K. (2006). Disrupted in schizophrenia 1: Building brains and memories. Trends in Molecular Medicine, 12, 255-261.
42. Porteous, D. J., et al. (2006). The genetics and biology of DISC1 - an emerging role in psychosis and cognition. Biological Psychiatry, 60, 123-131.
43. Preuss, T. (1995). Do rats have prefrontal cortex? The Rose- Woolsey-Akert program reconsidered. Journal of Cognitive Neuroscience, 7, 1-26.
44. Radley, J. J., et al. (2005). Reversibility of apical dendritic retraction in the rat medial prefrontal cortex following repeated stress. Experimental Neurology, 196, 199-203.
45. Ragland, J. D., et al. (2007). Neuroimaging of cognitive disability in schizophrenia: Search for a pathophysiological mechanism. International Review of Psychiatry, 19, 417-427.
46. Rakic, P. (2009). Evolution of the neocortex: a perspective from developmental biology. Nat Rev Neurosci, 10, 724-735.
47. Rapoport, J. L., et al. (2005). The neurodevelopmental model of schizophrenia: What can very early onset cases tell us? Current Psychiatry Reports, 7, 81-82.
48. Reinke, V., & White, K. P. (2002). Developmental genomic approaches in model organisms. Annu Rev Genomics Hum Genet, 3, 153-178.
49. Selemon, L. D., et al. (2007). Amphetamine sensitization alters dendritic morphology in prefrontal cortical pyramidal neurons in the non-human primate. Neuropsychopharmacology, 32, 919-931.
50. Selemon, L. D., et al. (1995). Abnormally high neuronal density in the schizophrenic cortex: A morphometric analysis of prefrontal area 9 and occipital area 17. Archives of General Psychiatry, 52, 805-818.
51. Selemon, L. D., et al. (2005). Direct and indirect effects of fetal irradiation on cortical gray and white matter volume in the macaque. Biological Psychiatry, 57, 83-90.
52. Shi, W., et al. (2001). Insertional mutagenesis of the adenoassociated virus type 2 (AAV2) capsid gene and generation of AAV2 vectors targeted to alternative cell-surface receptors. Human Gene Therapy, 12, 1697-1711.
53. Simons, J. S., et al. (2008). Separable forms of reality monitoring supported by the anterior prefrontal cortex. Journal of Cognitive Neuroscience, 20, 447-457.
54. Sun, D., et al. (2008). Progressive brain structural changes mapped as psychosis develops in "at risk" individuals. Schizophrenia Research
55. Wang, M., et al. (2007). Alpha2A-adrenoceptor stimulation strengthens working memory networks by inhibiting cAMPHCN channel signaling in prefrontal cortex. Cell, 129, 397-410.
56. Wilson-Annan, J. C., Blackwood, D. H., Muir, W., Millar, J. K., & Porteous, D. J. (1997). An allelic association study of two polymorphic markers in close proximity to a balanced translocation t(1:11) that co-segregates with mental illness. Psychiatr Genet, 7, 171-174.
57. Wu, Z., et al. (2006). Adeno-associated virus serotypes: Vector toolkit for human gene therapy. Molecular Therapy, 14, 316-327.
58. Yasumoto, F., et al. (2008). Genetic manipulation of brain cultures from the primates: A novel tool for molecular studies of neuropsychiatric disorders. Molecular Psychiatry, 13, 116-118.
59. Zaiss, A. K., & Muruve, D. A. (2008). Immunity to adenoassociated virus vectors in animals and humans: A continued challenge. Gene Therapy, 15, 808-816.